Pharscin Pharma: The company has received the drug re-registration approval notice

Pharscin Pharma announced that the company recently received the "Re-registration Approval Notice" for 1 chemical raw material drug and 1 pharmaceutical product issued by the Chongqing Municipal Drug Administration. Among them, the acceptance number for the chemical raw material drug Povidone Iodine is CYHZ2427221 Yu, and the notice number is 2025R088239, with a validity period of 24 months, until September 21, 2030. The acceptance number for the pharmaceutical product Injection Gabapentin Mesylate is CYHZ2427236 Yu, and the notice number is 2025R089146, with a specification of 0.1g, registered as a chemical drug, and the drug registration standard number is YBH09332022, with the drug approval number valid until September 24, 2030. This re-registration will ensure the normal production and sales of the pharmaceutical products and will not have a significant impact on the operating performance in the short term